Breast cancers with <i>EGFR</i> and <i>HER2</i> co-amplification favor distant metastasis and poor clinical outcome.

Oncol Lett · 2017 · PMC5696709 · PMID 29181099

Europe PMC DOI

hedged sentence

0.0620

closest p · 1.2× alpha

0.0620

boldest claim

The sentences

almost significantlyP=0.062so close (0.05 < p ≤ 0.1)

They were almost significantly correlated with clinical stage (P=0.062), HER2 overexpression (P=0.062) and local recurrence (P=0.053) ( Table IV ).

also in 555 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.